The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress.
about
PI3K/mTOR Inhibitors in the Treatment of Luminal Breast Cancer. Why, When and to Whom?The prognostic value of PI3K mutational status in breast cancer: a meta-analysis.Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer.The protective effects of maltol on cisplatin-induced nephrotoxicity through the AMPK-mediated PI3K/Akt and p53 signaling pathways
P2860
The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The Therapeutic Potential of P ...... Cancer: Rational and Progress.
@en
The Therapeutic Potential of P ...... Cancer: Rational and Progress.
@nl
type
label
The Therapeutic Potential of P ...... Cancer: Rational and Progress.
@en
The Therapeutic Potential of P ...... Cancer: Rational and Progress.
@nl
prefLabel
The Therapeutic Potential of P ...... Cancer: Rational and Progress.
@en
The Therapeutic Potential of P ...... Cancer: Rational and Progress.
@nl
P2093
P2860
P356
P1476
The Therapeutic Potential of P ...... Cancer: Rational and Progress.
@en
P2093
Afsane Bahrami
Gordon A Ferns
Majid Khazaei
Malihe Hasanzadeh
Mina Maftouh
Soodabeh Shahidsales
P2860
P304
P356
10.1002/JCB.26136
P577
2017-05-17T00:00:00Z